318.1 Direct application of flow cytometry for the determination of porcine blood group antigens
Man Zhang, People's Republic of China
318.2 Does dialysis modality or duration influence outcomes in simultaneous pancreas-kidney transplant recipients in the modern era?
Christopher J. Webb, United States
318.3 Intraoperative versus postoperative administration of rabbit antithymocyte globulin in pancreas transplantation
Marcelo Perosa, Brazil
318.4 Pancreas after islet and islet after pancreas transplantation offer a durable insulin independence to patients with type 1 diabetes mellitus and problematic hypoglycemia.
Sarah Gondek, United States
318.5 Emerging data from a study of tegoprubart for the prevention of rejection in kidney transplant recipients: Implications for a similar study in islet cell transplantation
Dr. Piotr Witkowski, United States
318.6 Nanofibrillated Cellulose Hydrogel with Stem Cells, Organoids and Wound Care
Dr. Lauri Paasonen, Finland
318.7 Biophysical properties of hiPSC-derived pancreatic organoids
Dr. Giuseppe Pettinato, United States
318.8 Analysis of human anti-porcine immune response in sensitized patients exposed to porcine hepatocytes